Development of a three-dimensional blood-brain barrier network with opening capillary structures for drug transport screening assays

Abbott, 2010, Structure and function of the blood–brain barrier, Neurobiol. Dis., 37, 13, 10.1016/j.nbd.2009.07.030 Abbott, 2013, Blood–brain barrier structure and function and the challenges for CNS drug delivery, J. Inherit. Metab. Dis., 36, 437, 10.1007/s10545-013-9608-0 Lajoie, 2015, Targeting receptor-mediated transport for delivery of biologics across the blood-brain barrier, Annu. Rev. Pharmacol. Toxicol., 55, 613, 10.1146/annurev-pharmtox-010814-124852 Pardridge, 1987, Human blood-brain barrier transferrin receptor, Metabolism, 36, 892, 10.1016/0026-0495(87)90099-0 Pang, 2011, Enhanced intracellular delivery and chemotherapy for glioma rats by transferrin-conjugated biodegradable polymersomes loaded with doxorubicin, Bioconjugate Chem., 22, 1171, 10.1021/bc200062q Prades, 2012, Delivery of gold nanoparticles to the brain by conjugation with a peptide that recognizes the transferrin receptor, Biomaterials, 33, 7194, 10.1016/j.biomaterials.2012.06.063 Kang, 2015, Enhancing glioblastoma-specific penetration by functionalization of nanoparticles with an iron-mimic peptide targeting transferrin/transferrin receptor complex, Mol. Pharm., 12, 2947, 10.1021/acs.molpharmaceut.5b00222 Ruan, 2018, Acid-responsive transferrin dissociation and GLUT mediated exocytosis for increased blood–brain barrier transcytosis and programmed glioma targeting delivery, Adv. Funct. Mater., 28, 10.1002/adfm.201802227 Hatherell, 2011, Development of a three-dimensional, all-human in vitro model of the blood–brain barrier using mono-, co-, and tri-cultivation Transwell models, J. Neurosci. Methods, 199, 223, 10.1016/j.jneumeth.2011.05.012 Appelt-Menzel, 2017, Establishment of a human blood-brain barrier Co-culture model mimicking the neurovascular unit using induced pluri- and multipotent stem cells, Stem Cell Rep., 8, 894, 10.1016/j.stemcr.2017.02.021 Stone, 2019, A novel transwell blood brain barrier model using primary human cells, Front. Cell. Neurosci., 13, 10.3389/fncel.2019.00230 Cucullo, 2011, The role of shear stress in Blood-Brain Barrier endothelial physiology, BMC Neurosci., 12, 40, 10.1186/1471-2202-12-40 Vatine, 2019, Human iPSC-derived blood-brain barrier chips enable disease modeling and personalized medicine applications, Cell Stem Cell, 24, 995, 10.1016/j.stem.2019.05.011 Wevers, 2018, A perfused human blood–brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport, Fluids Barriers CNS, 15, 23, 10.1186/s12987-018-0108-3 Ahn, 2020, Microengineered human blood–brain barrier platform for understanding nanoparticle transport mechanisms, Nat. Commun., 11, 175, 10.1038/s41467-019-13896-7 Bang, 2017, A low permeability microfluidic blood-brain barrier platform with direct contact between perfusable vascular network and astrocytes, Sci. Rep., 7, 8083, 10.1038/s41598-017-07416-0 Kulczar, 2017, Development of a direct contact astrocyte-human cerebral microvessel endothelial cells blood–brain barrier coculture model, J. Pharm. Pharmacol., 69, 1684, 10.1111/jphp.12803 Abbott, 2006, Astrocyte–endothelial interactions at the blood–brain barrier, Nat. Rev. Neurosci., 7, 41, 10.1038/nrn1824 Campisi, 2018, 3D self-organized microvascular model of the human blood-brain barrier with endothelial cells, pericytes and astrocytes, Biomaterials, 180, 117, 10.1016/j.biomaterials.2018.07.014 Herland, 2016, Distinct contributions of astrocytes and pericytes to neuroinflammation identified in a 3D human blood-brain barrier on a chip, PLoS One, 11, 10.1371/journal.pone.0150360 Duvernoy, 1983, The vascularization of the human cerebellar cortex, Brain Res. Bull., 11, 419, 10.1016/0361-9230(83)90116-8 Lee, 2020, 3D brain angiogenesis model to reconstitute functional human blood–brain barrier in vitro, Biotechnol. Bioeng., 117, 748, 10.1002/bit.27224 Park, 2019, Hypoxia-enhanced Blood-Brain Barrier Chip recapitulates human barrier function and shuttling of drugs and antibodies, Nat. Commun., 10, 2621, 10.1038/s41467-019-10588-0 Figarol, 2020, In Vitro self-organized three-dimensional model of the blood-brain barrier microvasculature, Biomed. Mater., 16 Figarol, 2020, Interstitial flow regulates in vitro three-dimensional self-organized brain micro-vessels, Biochem. Biophys. Res. Commun., 533, 600, 10.1016/j.bbrc.2020.09.061 Hikimoto, 2016, High-throughput blood- and lymph-capillaries with open-ended pores which allow the transport of drugs and cells, Advanced Healthcare Materials, 5, 1969, 10.1002/adhm.201600180 Ito, 2019, A human immortalized cell-based blood–brain barrier triculture model: development and characterization as a promising tool for Drug−Brain permeability studies, Mol. Pharm., 16, 4461, 10.1021/acs.molpharmaceut.9b00519 Furihata, 2016, Establishment and characterization of a new conditionally immortalized human astrocyte cell line, J. Neurochem., 136, 92, 10.1111/jnc.13358 Umehara, 2018, A new conditionally immortalized human fetal brain pericyte cell line: establishment and functional characterization as a promising tool for human brain pericyte studies, Mol. Neurobiol., 55, 5993, 10.1007/s12035-017-0815-9 Huang, 1991, Optical coherence tomography, Science, 254, 1178, 10.1126/science.1957169 Srinivasan, 2015, TEER measurement techniques for in vitro barrier model systems, J. Lab. Autom., 20, 107, 10.1177/2211068214561025 Nakagawa, 2009, A new blood–brain barrier model using primary rat brain endothelial cells, pericytes and astrocytes, Neurochem. Int., 54, 253, 10.1016/j.neuint.2008.12.002 Kurosawa, 2018, Expression and functional characterization of drug transporters in brain microvascular endothelial cells derived from human induced pluripotent stem cells, Mol. Pharm., 15, 5546, 10.1021/acs.molpharmaceut.8b00697 Pardridge, 1999, Blood-brain barrier biology and methodology, J. Neurovirol., 5, 556, 10.3109/13550289909021285 Shepro, 1993, Pericyte physiology, Faseb. J., 7, 1031, 10.1096/fasebj.7.11.8370472 Nishiguchi, 2018, In vitro 3D blood/lymph-vascularized human stromal tissues for preclinical assays of cancer metastasis, Biomaterials, 179, 144, 10.1016/j.biomaterials.2018.06.019 Cabezas, 2014, Astrocytic modulation of blood brain barrier: perspectives on Parkinson's disease, Front. Cell. Neurosci., 8, 211, 10.3389/fncel.2014.00211 Nishiguchi, 2014, Effects of angiogenic factors and 3D-microenvironments on vascularization within sandwich cultures, Biomaterials, 35, 4739, 10.1016/j.biomaterials.2014.01.079 Pardridge, 2005, The blood-brain barrier: bottleneck in brain drug development, NeuroRx, 2, 3, 10.1602/neurorx.2.1.3 Butt, 1990, Electrical resistance across the blood-brain barrier in anaesthetized rats: a developmental study, J. Physiol., 429, 47, 10.1113/jphysiol.1990.sp018243 Crone, 1982, Electrical resistance of brain microvascular endothelium, Brain Res., 241, 49, 10.1016/0006-8993(82)91227-6 Piantino, 2022, Brain microvascular endothelial cells derived from human induced pluripotent stem cells as in vitro model for assessing blood-brain barrier transferrin receptor-mediated transcytosis, Materials Today Bio, 14, 10.1016/j.mtbio.2022.100232 Easton, 1997, Two components of blood-brain barrier disruption in the rat, J. Physiol., 503, 613, 10.1111/j.1469-7793.1997.613bg.x Drolez, 2016, Selection of a relevant in vitro blood-brain barrier model to investigate pro-metastatic features of human breast cancer cell lines, PLoS One, 11, 10.1371/journal.pone.0151155 Molino, 2014 Yuan, 2009, Non-invasive measurement of solute permeability in cerebral microvessels of the rat, Microvasc. Res., 77, 166, 10.1016/j.mvr.2008.08.004 Reichel, 2003, An overview of in vitro techniques for blood-brain barrier studies, 307 Hewitt, 2006, The claudin gene family: expression in normal and neoplastic tissues, BMC Cancer, 6, 186, 10.1186/1471-2407-6-186 Fanning, 1998, The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton, J. Biol. Chem., 273, 29745, 10.1074/jbc.273.45.29745 Umeda, 2006, ZO-1 and ZO-2 independently determine where claudins are polymerized in tight-junction strand formation, Cell, 126, 741, 10.1016/j.cell.2006.06.043 Van Itallie, 2010, Occludin is required for cytokine-induced regulation of tight junction barriers, J. Cell Sci., 123, 2844, 10.1242/jcs.065581 Seetharaman, 1998, Multidrug resistance-related transport proteins in isolated human brain microvessels and in cells cultured from these isolates, J. Neurochem., 70, 1151, 10.1046/j.1471-4159.1998.70031151.x Dauchy, 2008, ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood–brain barrier, J. Neurochem., 107, 1518, 10.1111/j.1471-4159.2008.05720.x Lescale-Matys, 1993, Regulation of the ovine intestinal Na+/glucose co-transporter (SGLT1) is dissociated from mRNA abundance, Biochem. J., 291, 435, 10.1042/bj2910435 Fontaine, 1996, Use of rhodamine 123 to examine the functional activity of P-glycoprotein in primary cultured brain microvessel endothelial cell monolayers, Life Sci., 59, 1521, 10.1016/0024-3205(96)00483-3 Löscher, 2005, Blood-brain barrier active efflux transporters: ATP-binding cassette gene family, NeuroRx, 2, 86, 10.1602/neurorx.2.1.86 Sun, 2003, Drug efflux transporters in the CNS, Adv. Drug Deliv. Rev., 55, 83, 10.1016/S0169-409X(02)00172-2 Fishman, 1987, Receptor-mediated transcytosis of transferrin across the blood-brain barrier, J. Neurosci. Res., 18, 299, 10.1002/jnr.490180206 Calzolari, 2010, Transferrin receptor 2 is frequently and highly expressed in glioblastomas, Transl Oncol, 3, 123, 10.1593/tlo.09274 Qian, 2002, Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway, Pharmacol. Rev., 54, 561, 10.1124/pr.54.4.561 Johnsen, 2019, Targeting the transferrin receptor for brain drug delivery, Prog. Neurobiol., 181, 10.1016/j.pneurobio.2019.101665 Sade, 2014, A human blood-brain barrier transcytosis assay reveals antibody transcytosis influenced by pH-dependent receptor binding, PLoS One, 9, 10.1371/journal.pone.0096340 Lippmann, 2012, Human blood-brain barrier endothelial cells derived from pluripotent stem cells, Nat. Biotechnol., 30, 783, 10.1038/nbt.2247 Lippmann, 2014, A retinoic acid-enhanced, multicellular human blood-brain barrier model derived from stem cell sources, Sci. Rep., 4, 4160, 10.1038/srep04160